@ILugowska

Plenipotentiary Director for the International Affair, Head of the Early Phase Clinical Trials Unit and Precision Oncology in National Institute of Oncology.

 Warsaw, Poland
Joined October 2021
  • Tweets32
  • Following24
  • Followers92
🎥 Can European cancer systems remain sustainable in the years ahead? @WimvanHarten explains why #CancerEconomics, real-world data and access to innovation are becoming critical topics for CCs across Europe. These discussions will continue during #OECIOncologyDays in Warsaw.
1
1
31
♦️ OECI Excellent Practices – Part III How are cancer centres improving supportive care, professional training and patient recovery beyond treatment? This new selection highlights practical initiatives developed across Europe’s cancer centers.
1
1
1
55
mscs.oncotransfer.pl/?utm_so… submit the abstract by 6th June @OnkologiaPolska @NIO_PIB

5th Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care

Join us at 5th Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care on 3-5, September, 2025 in Warsaw, Poland.

mscs.oncotransfer.pl
2
4
222
🚨 Only 1 day left! The #CCI4EU Sixth Online Course on Data Sharing & Exchange is happening tomorrow—15 April, 13:00–17:30 CEST! Learn how to handle health data ethically, securely & efficiently. 🔗 Register now: e-eso.net/courses/25CC6#eso-… #CancerResearch #FAIRdata #DataSharing
2
2
261
📸 The #OECI Experts’ Consensus Conference is underway! OECI Vice-President @ILugowska opened the event in Brussels, emphasizing the need for a shared vision in Accreditation & Designation in cancer care. #CancerCare #CancerResearch #QualityStandards
1
10
8
819
📸 @ILugowska and the panelists during the session “From Diagnosis to Treatment – Best Practices and New Frontiers” at the #HADEA conference on #WorldCancerDay!
1
92
Day 1 of the CCI4EU Capacity Building Conference has come to a close, and it was an insightful day in Warsaw! 🎉 Discussions covered key topics like research innovation, AI in healthcare, and translating insights into clinical practice, among others. Stay tuned for updates!🔔
5
1
10
744
Save the date! #CCI4EU is announcing its second online course on Clinical Trials and Clinical Research, which will take place on 15 October 2024 from 13.30 - 16:30 (CEST). ➡️ To learn more and access the course, click here: e-eso.net/courses/24C2a
2
2
349
#ESMO23: Meet the editors of the ESMO Handbooks of Supportive & #PalliativeCare & Cancer in Adolescents and Young Adults, Ivana Bozovic-Spasojevic & Giannis Mountzios ⏰ 23/10, 10:00 CEST ESMO Member Lounge ow.ly/is2f50PZrZ9 #ESMObooks #AYACancer #supponc #pallonc
5
26
7,256
ESMO E-Learning: Prognostic and Predictive #Biomarkers in #HeadandNeckCancer by Lisa Licitra, @drsalvoalfieri, @BubiSilvi & Simone Rota. ESMO Members can take the CME test and receive 1 ESMO-MORA point. ow.ly/gL3P50Pnqop #hncsm
1
2
15
3,480
The latest ESMO Guidelines webinar on #ovariancancer is now available on-demand on OncologyPRO. Access the resources with your free ESMO account and learn how these recommendations can assist you in your daily practice 👉 ow.ly/6xu850Pntlq @CoquardRay @bpellegrino89 #GynCSM
4
20
4,589
📢 The updated ESMO Handbook of Nutrition and Cancer (2nd ed.) This fully-revised, peer-reviewed publication looks into many relevant topics & includes two new chapters on developing areas of interest. PDF, eReaders & Kindle format. ow.ly/jxeE50P9jTi #ESMObooks @ILugowska
10
1
18
6,956
Iwona Lugowska retweeted
Sébastien Moine@s_moine11 Apr 2023
‘‘Decision making should not only be viewed as the consequence of available prognostic information. The decisions patients make (e.g. to start, withhold or discontinue anticancer therapy) may themselves have an impact on future prognosis.’’ True for QoL too, not only survival!
ESMO - Eur. Oncology
@myESMO11 Apr 2023
📢 Prognostic evaluation in patients with #advancedcancer in the last months of life: ESMO Clinical Practice Guideline. Prognostication and communication algorithm also included. ow.ly/tifo50NFMFG #PallOnc @ESMO_Open @curijoey @s_moine
4
6
3,432
Iwona Lugowska retweeted
ESMO - Eur. Oncology
@myESMO7 Apr 2023
The ESMO Virtual Mentorship Programme offers ESMO Members under 40 the opportunity to develop their skills, knowledge & experience to progress in their career w/ a 1:1 mentorship. 👇Apply now, deadline 16 April 2023 ow.ly/CTqU50NAOTb #ESMOYOC @matteolambe
20
7
37
28,380
Really appreciated this #ESMOSarcomaAndRareCancers23 session dedicated to Young Oncologists career in #rarecancers challenges and opportunities @WTapMD @ILugowska @BenWestphalen @DrLizConnolly @pawel_sobczuk
4
27
2,049
Nowe badanie ANNASARC dla chorych na mięsaki tkanek miękkich, u których wystąpiła progresja choroby w czasie leczenia co najmniej 1. linią chemioterapii z powodu choroby nieoperacyjnej lub przerzutowej @AgencjaBadanMed @NIO_PIB @sarcoma_pl @moleculinbio @OnkologiaPolska
8
14
1,071
Very interesting start of #ENA2022 on the role of ctDNA in clinical trials. Tests, endpoints, impact on patients’ QoL etc. & critical discussions on RECIST.Nice talk also from @MIgnatiadis on line. Modern gender imbalance of the panel of experts this morning @EORTC @lillian_siu
3
17
New: ESMO Handbook of Cancer in Adolescents & Young Adults: focusing on all aspects on #AYAoncology including diagnosis, treatment, psychosocial aspects and rehabilitation. ow.ly/2JPj50KGfAe #ayacsm #AYACancer @NivenMehra @g_mountzios
6
16
📢@EORTC Past Presidents Forum, with long-standing friends including 👉Martine Piccart, President 2006-2009 & ECO President 2014-2015 👉@Winette_vdGraaf, EORTC President & ECO Board Member 👉@jeanyvesblay, EORTC President 2009 - 2012 #EORTC60
4
6
#ESMO22 Highlights - DeFi: A Phase 3, Randomised Controlled Trial of Nirogacestat Versus Placebo for Progressing #DesmoidTumours with Bernd Kasper. ow.ly/ki4K50KG8x5 #rarecancer
3
1
6
Load more